ReviewDiscover oncology2025

Epigenetic reprogramming as the nexus of cancer stemness and therapy resistance: implications for biomarker discovery.

Chu Xin Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.